Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-activity studies on antidepressant 2,2-diarylethylamines.

B E Maryanoff, S O Nortey, J F Gardocki

    Journal of Medicinal Chemistry
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Magnamycin: toxicity in experimental animals.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Tetracycline-microbiologic, pharmacologic, and clinical evaluation.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Acute and chronic toxicity of anisomycin in experimental animals.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Stereochemistry and mechanism of the Wittig reaction. Diasteromeric reaction intermediates and analysis of the reaction course.

    Journal of the American Chemical Society·2012
    Same author

    Correction. stereochemistry of the wittig reaction. Effect of nucleophillic groups in phosphonium ylide.

    Journal of the American Chemical Society·2011
    Same author

    Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans.

    European journal of drug metabolism and pharmacokinetics·2005

    Diethanolamine 4, a 2,2-diarylethylamine derivative, shows potent antidepressant activity in the tetrabenazine test. Minor structural changes significantly reduce its efficacy, highlighting the importance of specific molecular features for antidepressant action.

    Area of Science:

    • Medicinal Chemistry
    • Neuropharmacology
    • Drug Discovery

    Background:

    • Antidepressant drug discovery is crucial for treating mood disorders.
    • 2,2-diarylethylamine derivatives represent a class of compounds with potential CNS activity.

    Purpose of the Study:

    • To evaluate the antidepressant potential of novel 2,2-diarylethylamine derivatives.
    • To investigate structure-activity relationships (SAR) for antidepressant activity.

    Main Methods:

    • Screening of 2,2-diarylethylamine derivatives using the tetrabenazine (TBZ) test.
    • Assessment of exploratory activity and ptosis in animal models.
    • Evaluation in the maximal electroshock seizure threshold test.

    Main Results:

    Related Experiment Videos

    • Diethanolamine 4 (McN-4187) demonstrated significant antidepressant activity (ED50 values of 15 mg/kg and 1.5 mg/kg).
    • Minor structural modifications to Diethanolamine 4, such as altering phenyl substituents or replacing them with other groups, substantially reduced its potency.
    • The bisethanol functionality was found not to be essential for activity, with some analogs showing comparable TBZ assay results.

    Conclusions:

    • Diethanolamine 4 is a potent antidepressant candidate within the 2,2-diarylethylamine class.
    • Specific structural features of Diethanolamine 4 are critical for its observed antidepressant activity.
    • Further optimization of these derivatives may lead to novel antidepressant therapeutics.